Samsung Biologics achieved a record-breaking earnings performance in the first quarter of 2024, reporting the highest-ever quarterly revenue and operating profit, thanks to increased production from Plant 4 and the expansion of its biosimilar business.The biopharmaceutical company reported a consoli
LG Chem has announced a partnership with EuBiologics to enhance the domestic production capabilities of pediatric vaccines in Korea.The collaboration focuses on developing the hexavalent vaccine LR20062, which is designed to protect against six diseases -- diphtheria, tetanus, pertussis (whooping co
VUNO said its AI-based retinal imaging diagnostic support solution, VUNOMED Fundus AI, has received approval from the Ministry of Food and Drug Safety (MFDS) for an integrated review of innovative medical devices.This marks it as the first AI-powered ophthalmic device in the country to gain such rec
Onconic Therapeutics, a subsidiary of Jeil Pharma Holdings, said it received approval from the Ministry of Food and Drug Safety for Jaqbo (ingredient: Zastaprazan), a drug for the treatment of gastroesophageal reflux disease (GERD) and Korea's 37th domestically developed new drug.Jaqbo represents a
Severance Hospital researchers have identified a promising method to rejuvenate the effectiveness of natural killer cells in combating multiple myeloma, a serious form of blood cancer.Multiple myeloma is characterized by the malignant transformation of plasma cells, which are crucial to the body's i
The Research Investment for Global Health Technology Foundation, commonly known as the RIGHT Foundation, said it opened its grant application aimed at significantly enhancing health equity in infectious disease sectors within low- and middle-income countries. The foundation is focusing its funding o
Viatris Korea celebrated 25 years of Lipitor (atorvastatin) sales in Korea, highlighting its pivotal role in dyslipidemia treatment and cardiovascular diseases (CVD) prevention at a press conference in Seoul on Wednesday.After its launch in 1997, Lipitor became the top-prescribed statin in Korea by
Chong Kun Dang said it has entered into a licensing agreement with Curigin, a local gene therapy developer, for the latter's CA102, a gene therapy candidate targeting superficial bladder cancer.Founded in 2016, Curigin has pioneered the development of siRNA technologies capable of suppressing multip
Hanmi Pharmaceutical said it has entered into a clinical trial collaboration and supply agreement (CTCSA) with Merck & Co., Inc., known as MSD outside the U.S. and Canada.The partnership is set to advance the clinical research of Hanmi's dual-antibody therapy, BH3120, combined with MSD's immunothera
Samsung Bioepis said it has secured final product approval from the European Commission (EC) for its latest biosimilar, Pyzchiva, also known as SB17, a biosimilar candidate referencing Stelara.Stelara, originally developed by Janssen, is used for treating plaque psoriasis, psoriatic arthritis, Crohn
Jung Kwan Jang, Korea’s top ginseng product manufacturer, said it conducted a seminar focused on the efficacy and safety of red ginseng during the International Conference on the Science of Botanicals, held in Oxford, Miss., from April 15 to 18.The International Conference on the Science of Botanica
GC Biopharma said it has submitted an investigational new drug (IND) application and applied for Fast Track Designation with the U.S. FDA for GC1130A, an intracerebroventricular (ICV) enzyme replacement therapy (ERT) drug for Sanfilippo Syndrome Type A (MPS IIIA), jointly developed with Korean biote
Kakao Healthcare said Tuesday that it has signed a business agreement with global food care and catering company OURHOME to develop AI-based ultra-personalized healthcare solutions jointly.Kakao Healthcare CEO Hwang Hee and OURHOME CEO Koo Ji-eun signed the memorandum of understanding at Kakao Healt
Curocell, a chimeric antigen receptor-T (CAR-T) developer, has applied for Anbal-cel, its CAR-T candidate, to be included in the Ministry of Food and Drug Safety (MFDS)’s Advanced Biomedicine Expedited Approval System.The system is designed to facilitate the rapid market entry of innovative medicine
In alignment with Earth Day, an annual event on April 22, Bayer Korea began its annual "Glück for Green" plogging campaign, an initiative designed to foster sustainable practices among its employees. Plogging refers to picking up rubbish while jogging or walkingThis year marks the third installment
Korea's largest private equity firm, MBK Partners, has agreed to purchase a majority stake in Geo-Young, the nation's top pharmaceutical distributor, from Blackstone for approximately 1.95 trillion won ($1.4 billion), Seoul Economic Daily said on Monday. This deal marks the largest transaction of it
The importance of early diagnosis of prostate cancer cannot be overstated. According to data from the World Cancer Research Fund International, prostate cancer is the second most common type of cancer among men globally, following lung cancer.Early detection significantly increases treatment options
Bridge Biotherapeutics, a Korean biotech firm, announced positive feedback from the third Independent Data Monitoring Committee (IDMC) meeting to continue the phase 2 clinical trial of BBT-877, a drug candidate for the treatment of idiopathic pulmonary fibrosis (IPF).IPF is a severe and chronic lung
The Ministry of Food and Drug Safety has granted approval to two more digital therapeutic (DTx) devices, developed by Nunaps and Share&Service. These devices, which are the third and fourth authorized DTx in the country, utilize software to assist in cognitive improvement and respiratory rehabilitat
3Bigs, a Korean company specializing in bio big data-based health management solutions, said it entered a distribution partnership with Neo-Science, a bio-health enterprise located in Abu Dhabi, the UAE.Under the accord, Neo-Science will manage the sales of several key 3Bigs products, including the